Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
COMPASS Pathways plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CMPS
Nasdaq
2836
compasspathways.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for COMPASS Pathways plc
Is Your Mind Ready to Consider Investing in Psychedelics Stocks?
- Nov 30th, 2024 1:57 am
Compass Pathways to Participate in December Investor Conferences
- Nov 25th, 2024 9:00 pm
COMPASS Pathways plc (NASDAQ:CMPS) has caught the attention of institutional investors who hold a sizeable 29% stake
- Nov 25th, 2024 11:26 am
Compass Pathways to participate in Stifel 2024 Healthcare Conference
- Nov 14th, 2024 12:44 pm
Compass Pathways cuts 30% of workforce on Phase 3 trial delays
- Nov 2nd, 2024 1:25 pm
Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...
- Nov 1st, 2024 3:00 pm
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript
- Nov 1st, 2024 1:00 am
Compass delays anticipated psilocybin readout, cuts staff
- Oct 31st, 2024 12:03 pm
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates
- Oct 31st, 2024 10:30 am
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024
- Oct 24th, 2024 10:30 am
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit
- Sep 23rd, 2024 11:00 am
Compass Pathways to participate in three investor conferences in September
- Aug 28th, 2024 10:00 am
Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks
- Aug 25th, 2024 1:06 pm
More promise for psilocybin in depression but safety remains a concern
- Aug 19th, 2024 11:13 am
COMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth Conference
- Aug 6th, 2024 12:00 pm
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript
- Aug 2nd, 2024 3:30 am
Compass Pathways announces second quarter 2024 financial results and business highlights
- Aug 1st, 2024 10:30 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
- Jul 28th, 2024 10:05 pm
Compass Pathways to announce second quarter financial results on August 1, 2024
- Jul 24th, 2024 11:01 am
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
- Jul 8th, 2024 11:45 am
Scroll